The need to scale up HIV indicator condition-guided testing for early case-finding: a case-control study in primary care by Joore, I.K. (Ivo K.) et al.
Joore et al. BMC Family Practice  (2016) 17:161 
DOI 10.1186/s12875-016-0556-2RESEARCH ARTICLE Open AccessThe need to scale up HIV indicator
condition-guided testing for early
case-finding: a case-control study in
primary care
Ivo K. Joore1*, Denise E. Twisk2, Ann M. Vanrolleghem3, Maria de Ridder3, Suzanne E. Geerlings4,
Jan E. A. M. van Bergen1,5 and Ingrid V. van den Broek2Abstract
Background: European guidelines recommend offering an HIV test to individuals who display HIV indicator
conditions (ICs). We aimed to investigate the incidence of ICs in primary care reported in medical records prior to
HIV diagnosis.
Methods: We did a cross-sectional search in an electronic general practice database using a matched case-control
design to identify which predefined ICs registered by Dutch GPs were most associated with an HIV-positive status
prior to the time of diagnosis.
Results: We included 224 HIV cases diagnosed from 2009 to 2013, which were matched with 2,193 controls.
Almost two thirds (n = 136, 60.7%) of cases were diagnosed with one or more ICs in the period up to five years
prior to the index date compared to 18.7% (n = 411) of controls. Cases were more likely to have an IC than controls:
in the one year prior to the index date, the odds ratio (OR) for at least one condition was 11.7 (95% CI: 8.3 to 16.4).
No significant differences were seen in the strength of the association between HIV diagnosis and ICs when
comparing genders, age groups or urbanisation levels. There is no indication that subgroups require a different
testing strategy.
Conclusions: Our study shows that there are opportunities for IC-guided testing in primary care. We recommend
that IC-guided testing be more integrated in GPs’ future guidelines and that education strategies be used to
facilitate its implementation in daily practice.
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Primary healthcareBackground
In 2014, UNAIDS set the challenging goal to end the
AIDS epidemic by 2030 [1]. UNAIDS stated that world-
wide in 2020, 90% of all people living with HIV should
be aware of their HIV status, 90% of all diagnosed HIV
infected people should receive antiretroviral therapy, and
of that group 90% should achieve viral suppression [1].* Correspondence: i.k.joore@amc.uva.nl
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with HIV, had been diagnosed with the infection. In
total, 16,821 had started treatment, and of these 15,463
had achieved viral suppression [2]. Our country is thus
close to achieving the UNAIDS ’90-90-90’ target of 73%
of all people with HIV virally suppressed [1]. However,
in recent years there are still approximately 1000 newly
diagnosed HIV infections in the Netherlands each year
[2]. In 2014, 44% of newly diagnosed persons presented
late for care (CD4 count < 350 cells/mm3 or with an
AIDS-defining event regardless of CD4 count) [2].le is distributed under the terms of the Creative Commons Attribution 4.0
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onstrated public health benefit of early treatment [3].
Recently, data appeared that proved that initiating anti-
retroviral therapy after HIV diagnosis regardless of CD4
count improved the health prospects of the person being
treated [4, 5]. These findings reinforce the need to detect
HIV as early as possible and the importance of linkage
to care.
People who are unaware of their infection play an im-
portant role in maintaining the HIV epidemic [6]. Dutch
general practitioners (GPs) act as gatekeeper to clinical
care and are an important point of referral into specia-
lised HIV care [7]. Every Dutch person is required to
register with a GP and 75% contacts their GP at least
once per year [8]. About two thirds of sexually transmit-
ted infection (STI) care is provided by GPs and one third
by STI clinics [7, 9]. The costs of STI tests and medica-
tion at the GP are covered by mandatory health insur-
ance, only after the out-of-pocket maximum has been
reached [10]. One third of all HIV infections in the
Netherlands are diagnosed by GPs [2]. A Dutch study
also showed that GPs reach groups of persons at risk of
HIV that are not reached by STI clinics, which under-
lines the important role of primary care in fighting the
HIV epidemic [2, 11]. In several European countries, pri-
mary care is a setting for creating opportunities to detect
HIV as early as possible [11–14].
Dutch GP guidelines already promote provider-
initiated HIV testing among high-risk populations, but
this strategy alone shows limits in the implementation to
detect HIV-infected people [11]. For example, GPs may
find it difficult to have complex conversations about sex-
ual risk behaviour [15, 16]. The deployment of the HIV
indicator condition (IC)-guided testing strategy in pri-
mary care is a new development that was included in an
update of Dutch STI guidelines for GPs that appeared at
the end of 2013 [17]. ICs are defined as conditions that
are associated with a prevalence of undiagnosed HIV in
excess of 0.1% and AIDS-defining conditions [18, 19].
A UK case-control study in primary care found
multiple ICs that were associated with a subsequent HIV
diagnosis [20].
A Dutch case-control pilot study conducted in a
higher HIV-prevalence area showed that one or more
ICs were observed prior to diagnosis among cases com-
pared to controls [21]. The results of this study cannot
be extrapolated to the Dutch national level, as it was
performed in six general practices that were located in a
higher HIV-prevalence area.
The aim of the present study was to investigate the in-
cidence of ICs reported in medical records up to five
years prior to HIV diagnosis among HIV cases compared
to matched controls using a primary care database rep-
resentative of the general population.Methods
We carried out a retrospective population-based nested
case-control study; data were retrieved from electronic
patient medical records (EMRs).
Data source
The Integrated Primary Care Information (IPCI) data-
base is a longitudinal primary care research database
managed at the Erasmus University Medical Center in
Rotterdam, the Netherlands [22, 23]. This database con-
tains the EMRs of 747 Dutch GPs [23]. The EMRs
contain demographic information (gender, date of birth
and living area) and medical information routinely col-
lected during consultations, including laboratory results,
medical diagnoses, prescriptions and treatments. The
standard information recorded in EMRs does not
include sexual orientation or ethnicity. All patient infor-
mation in the IPCI database is anonymous. The database
incorporates a considerable proportion (about 10%) of
the total Dutch population, making it representative of
the general population, with some underrepresentation
of elderly people living in nursing homes [24]. The
Supervisory Board of the IPCI database approved the
use of IPCI data for our study. Approval by an ethics
committee was not necessary for this retrospective study
because only anonymous data were used. The
researchers had no access to the identity the patients or
the GPs.
Study population
The study population from which cases and controls
were extracted consisted of all persons in the database
who were 18 years or older and registered at one of the
GP practices during the period from 1 January 2009 up
to 31 December 2013 (total of five years).
Cases were defined as HIV-positive individuals. If no
HIV diagnosis was recorded, an individual could act as
control.
Potential cases were selected by extracting the Inter-
national Classification of Primary Care (ICPC) B90 code
‘HIV infection’ from the EMRs [25]. In addition, EMRs
that contain the words ‘HIV’ and ‘AIDS’ in the open text
evaluation fields were extracted. EMRs with a B25 code
(‘fear of HIV/AIDS’) but without a B90 code were ex-
cluded, because these were people who had visited their
GP for an HIV test but were not diagnosed with HIV.
Potential cases were manually validated. The extrac-
tion of potential cases was performed in duplicate by
two of the project’s researchers (IKJ and DT). Discrepan-
cies were discussed until consensus was reached. Uncer-
tain potential cases were presented to a third researcher
(IvdB). Cases were matched to controls (up to a
maximum of 10) for age, gender and registration at the
same general practice in the same calendar year and at
Table 1 Operational definitions of HIV indicator conditions
HIV indicator conditions [18] Operational definition of predefined HIV
indicator conditions used for search in
the EMRs*
Sexually transmitted
infections
Chlamydia, gonorrhoea, syphilis, hepatitis
B, genital herpes, lymphogranuloma
venereum, condyloma acuminata and
trichomoniasis
Chlamydia Chlamydia
Gonorrhoea Gonorrhoea
Syphilis Syphilis
Acute or chronic
Hepatitis B
Hepatitis B
Genital Herpes Genital herpes
Lymphogranuloma
venereum
Lymphogranuloma venereum
Condyloma acuminata Condyloma acuminata
Trichomoniasis Trichomoniasis
Hepatitis A Hepatitis A
Acute or chronic Hepatitis C Hepatitis C
Herpes zoster Herpes zoster
Severe or atypical psoriasis Psoriasis
Seborrheic dermatitis/
exanthema
Seborrhoeic dermatitis
Cervical dysplasia Cervical dysplasia
Community-acquired
pneumonia
Pneumonia
Unexplained oral candidiasis Oral candidiasis
Mononeuritis Mononeuritis
Peripheral neuropathy Peripheral neuropathy
Mononucleosis-like illness Mononucleosis-like illness is defined as
illness with at least two of these
symptoms: rash, fever and swollen lymph
glands, with or without muscle aches,
sore throat and feeling sick.
Unexplained fever Fever
Unexplained weight loss Weight loss
Unexplained
lymphadenopathy
Lymphadenopathy
Unexplained chronic
diarrhoea
Diarrhoea
Unexplained leukocytopenia
lasting > 4 weeks
Leukocytopenia
Unexplained
thrombocytopenia
lasting > 4 weeks
Thrombocytopenia
Unexplained chronic renal
impairment
Chronic renal impairment
*EMR Electronic medical record
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to the index date (date of HIV diagnosis in cases and
matched date in the control group). Controls were
selected from persons without an ICPC B90 code in
their EMRs. Cases could be selected as controls until the
year before they became a case. The number of selected
controls per case depended on the availability. Selecting
as many controls as possible per case ensures maximum
statistical power in matched case-control studies to
detect differences in the occurrence of rare events [26].
For the confirmed cases within the study period
(2009–13) and their matched controls, a history of five
years of patient EMRs of validated registration time be-
fore the index date was included if available, but at least
one year was required (i.e. practices are included in the
IPCI database after data collection checks; information
or EMRs prior to validation are only included as ‘patient
history’, and are not counted as validated registration
time). The inclusion of the cases was limited by the start
date of the GP participation in IPCI or by the date the
patient registered with the GP prior to the index date
(date of HIV diagnosis).
HIV indicator conditions
A total of 26 predefined ICs were selected from the list of
ICs with an associated (undiagnosed) HIV prevalence of
>0.1% (see Table 1) [18, 21]. The selection criteria for
inclusion ICs were described in an earlier pilot study and
included only conditions that Dutch GPs may diagnose
themselves (as opposed to the ones diagnosed by medical
specialists/in secondary care) [21]. Conditions that are
unlikely to be diagnosed by a GP were excluded. Where
necessary, specific case definitions (‘operational defini-
tions’) were developed for manual searching in the EMRs
of the IPCI database. Also, for each IC ICPC code, com-
mon medical terminology, abbreviations and synonyms
used by the GP or the patient were marked in the EMRs.
A distinction was made between the search for specific
diagnoses and that for more general/common symp-
toms. ICs defined as diagnoses were searched for in the
complete text of the EMR, while the symptoms were
only searched for in the open text evaluation fields of
the EMRs, where most of the important symptoms are
reported.
A mononucleosis-like illness was considered if at least
two of the following symptoms were present in the
EMR’s open evaluation text fields: fever, swollen lymph
glands and rash with or without pharyngitis, muscle
aches and feeling sick. If there were symptoms in the
evaluation text fields that might indicate a
mononucleosis-like illness, we also searched the other
text fields for validating evidence.
The duration of the search period was one to five years
prior to the index date, depending on the availability inthe EMR. The history time of a control was matched to
the history time of its cases, so that cases did not have a
history time different from that of their matched
controls.
Fig. 1 Number of confirmed HIV diagnosis in the IPCI
database 2009-2013
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prior to index date was classified as 1) yes recorded (at
least once); 2) absent; and 3) uncertain. Incident ICs and
their date of diagnosis were manually transferred into a
validation tool. If a person had multiple consultations
for the same IC, we used the most recent one before the
index date that was recorded by the GP. The search for
incidence ICs was carried out in duplicate by the same
two researchers (IKJ, DT). They were not blinded for
HIV diagnosis in the EMRs as this was not possible due
to technical limitations. A third researcher (IvdB) was
consulted if consensus could not be reached or if ICs
were classified as uncertain.
HIV testing in persons diagnosed with STIs
According to the Dutch GP guidelines, persons who are
diagnosed with chlamydia, gonorrhoea, syphilis or hepa-
titis B should be advised to have an HIV test. [17] We
did a search in the EMRs in the case-control dataset to
find out whether patients diagnosed with STIs had been
tested for HIV in the same or follow-up consultation(s)
within a time window of three months.
Statistical analyses
We performed conditional logistic regression to investi-
gate whether having at least one STI or IC prior to the
index date was associated with testing HIV positive. We
performed exact conditional logistic regression to inves-
tigate whether specific ICs prior to the index date were
associated with testing HIV positive. For very small or
zero incidence rates among the cases or controls, odds
ratios (ORs) were estimated with ‘median unbiased esti-
mate’. Sensitivity analyses were performed, comparing
the associations between ICs and HIV diagnosis when
including versus not including unconfirmed (classified as
‘uncertain’) ICs. Furthermore, the interaction of presence
of any IC with gender, age group and urbanisation level
was tested in a conditional logistic regression model.
Confidence intervals for the percentages of HIV test-
ing in STI diagnosed patients were obtained by Wilson
score method [27].
Analyses were performed with SPSS (version 19.0, IBM,
USA) except for the exact logistic regression, for which
STATA (version 13.1, College Station, TX) was used.
Results
Patient characteristics of cases and controls
The eligible study population (18 years and older) con-
sisted of the EMRs of 1,255,440 persons (Fig. 1). The
search algorithm identified 2,068 patients as potential
HIV-positive cases. First, patients with a B25 code (‘fear
of HIV/AIDS’) but without a B90 code (‘HIV infection’)
were excluded (n = 452). Of the remaining 1,616 poten-
tial cases, 897 patients were excluded because no HIVdiagnosis was reported in the consultation. For the 719
potential cases a more in-depth evaluation was con-
ducted using the complete EMR to confirm HIV diagno-
sis; the diagnosis was confirmed in 613 cases. Patients
with an HIV diagnosis outside the study period (n = 319)
or outside the validated IPCI time (n = 70) were
excluded.
Table 3 The proportion of persons diagnosed with one or
more STI or HIV indicator condition among HIV cases compared
to matched controls
Cases
(N = 224)
Controls
(N = 2,193)
N % N % OR 95 % CI P value
Number of STIs per person in one year prior to index date
None 174 78.1 2,169 98.9
At least one 50 21.9 24 1.1 32.2 17.7 to 58.5 <0.0001
Number of STIs per person up to five years prior to index date
None 142 63.4 2,125 96.9
At least one 82 36.6 68 3.1 25.3 16.1 to 39.9 <0.0001
Number of HIV indicator conditions per person one year prior to index date
None 125 55.8 2,032 92.7
At least one 99 44.2 161 7.3 11.7 8.3 to 16.4 <0.0001
Number of HIV indicator conditions per person up to five years prior to
index date
None 88 39.3 1,782 81.3
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matched with 2,193 controls (HIV-negative individuals).
The majority (88.4%) of cases were male, the median age
was 40 (IQR 31 to 47) and 55.8% lived in areas with a
high level of urbanisation (Table 2).
HIV indicator conditions
Almost two thirds (n = 136, 60.7%) of cases had been di-
agnosed with one or more ICs up to five years prior to
the index date, compared to 18.7% (n = 411) of controls
(Table 3).
Cases had a higher probability of having IC than con-
trols: in the one year prior to the index date, the OR for
at least one condition compared to no condition was
11.7 (95% CI: 8.3 to 16.4) (Table 3).
Recorded STI episodes in the one year prior to the index
date were also associated with the occurrence of HIV: for
at least one STI compared to no STI the OR was 32.2
(95% CI: 17.7 to 58.5). The proportions of the number ofTable 2 Patient characteristic of cases and matched controls
Cases Controls
N % N %
Total study population 224 2,193
History prior to index date
Between 1 and 2 years 30 13.4 289 13.2
Between 2 and 3 years 27 12.1 270 12.3
Between 3 and 4 years 7 3.1 70 3.2
Between 4 and 5 years 15 6.7 150 6.8
More than 5 years 145 64.7 1,414 64.5
Gender
Male 198 88.4 1,933 88.1
Female 26 11.6 260 11.9
Age at index date
18 to 39 years 80 35.7 788 35.9
40 to 49 years 97 43.3 946 43.1
50 to 59 years 32 14.3 309 14.1
60 years and older 15 6.7 150 6.8
Urbanisation level
very high (>2,500 addresses per km2) 76 33.9 633 28.9
high (1,500 - 2,500 addresses per km2) 49 21.9 522 23.8
medium (1,000 - 1,500 addresses per km2) 21 9.4 252 11.5
low (500 - 1,000 addresses per km2) 9 4.0 113 5.2
not urban/rural (<500 addresses per km2) 4 1.8 61 2.8
Missing 65 29.0 612 27.9
Socially deprived area (on 4-digit postal code area)a
Yes 26 11.6 226 10.3
No 198 88.4 1,967 89.7
aSocially deprived areas are defined by various socioeconomic indicators
determined per 4-digit postal code
At least one 136 60.7 441 18.7 8.1 5.9 to 11.1 <0.0001
Statistical significance indicated in boldSTIs and ICs per person prior to index date are reported
in Additional file 1.
The ICs most strongly associated with the occurrence
of HIV were gonorrhoea (OR = 77.1, 95% CI: 27.3 to
300.3) and syphilis (OR = 52.0, 95% CI: 17.6 to 208.2)
(Table 4). Several ICs were not observed in either the
cases or the control group, i.e. chronic renal impairment,
hepatitis A and leukocytopenia.
When uncertain diagnoses were included in the re-
ported ICs, lymphogranuloma venereum (OR = 20.0;
95% CI: 1.0 to 1179.9) was also associated with the oc-
currence of HIV diagnosis.
The OR for the occurrence of ICs was higher for men
than for women, but the difference was not significant
(see Table 5). Age group or urbanisation level also had
no significant effect on the strength of the association
between HIV diagnosis and ICs.
HIV testing in persons diagnosed with STIs
In 32.1% (95% CI: 17.9 to 50.7) of persons diagnosed with
syphilis (9/28 of the cases and controls) no HIV test was
reported in the EMRs in the same or follow-up consulta-
tion(s) within a time window of three months; for gonor-
rhoea this was 44.7% (95% CI: 30.1 to 60.3), (17/38), for
hepatitis B 61.5% (95% CI: 35.5 to 82.3), (8/13) and for
chlamydia 54.2% (95% CI: 40.3 to 67.4), (26/48).
Discussion
Since 2012, European guidelines recommend IC-guided
testing in primary care. This new strategy is also men-
tioned in the updated Dutch national STI guideline for
Table 4 The incidence of clinical- and symptoms-related HIV indicator conditions among HIV cases compared to matched controls
Cases (N = 224) Controls (N = 2,193)
N % N % OR 95% CI P value
Clinical diagnosis
Gonorrhoea 33 14.7 5 0.2 77.1 27.3 to 300.3 <0.0001
Syphilis 22 9.8 6 0.3 52.0 17.6 to 208.2 <0.0001
Leukocytopenia* 2 0.9 0 24.1 1.9 to ∞* 0.02
Trichomoniasis 2 0.9 1 0 20.0 1.0 to 1,179.9 0.05
Hepatitis B 9 4.0 4 0.2 22.5 6.3 to 100.0 <0.0001
Hepatitis C 3 1.3 2 0.1 15.0 1.7 to 179.6 0.01
Thrombocytopenia 4 1.8 4 0.2 12.0 2.0 to 83.1 <0.01
Lymphogranuloma venereum 1 0.4 1 0 10.0 0.1 to 785.0 0.35
Mononeuritis 1 0.4 1 0 10.0 0.1 to 785.0 0.35
Cervical dysplasia 6 2.7 11 0.5 8.1 2.0 to 34.6 <0.01
Chlamydia 20 8.9 28 1.3 8.5 4.2 to 17.0 <0.0001
Genital herpes 8 3.6 7 0.3 10.2 3.1 to 33.7 0.0001
Condyloma acuminata 19 8.5 25 1.1 7.9 4.0 to 15.1 <0.0001
Oral candidiasis 3 1.3 7 0.3 4.5 0.7 to 21.3 0.11
Mononucleosis-like illness 3 1.3 6 0.3 4.9 0.8 to 23.1 0.09
Pneumonia 25 11.2 79 3.6 3.6 2.1 to 5.9 <0.0001
Herpes zoster 10 4.5 32 1.5 3.2 1.4 to 6.9 <0.01
Chronic renal impairment* 0 0 3 0.1 2.6 0 to 24.2 1.00
Hepatitis A* 0 0 4 0.2 1.9 0 to 15.1 1.00
Psoriasis 6 2.7 34 1.6 1.8 0.6 to 4.5 0.30
Seborrhoeic dermatitis 7 3.1 60 2.7 1.2 0.4 to 2.8 0.83
Symptoms
Weight loss 7 3.1 19 0.9 3.9 1.3 to 10.1 0.01
Lymphadenopathy 9 4.0 31 1.4 3.2 1.3 to 7.3 0.01
Fever 8 3.6 29 1.3 2.8 1.1 to 6.3 0.03
Diarrhoea 18 8.0 79 3.6 2.5 1.4 to 4.4 <0.01
Peripheral neuropathy 5 2.2 25 1.1 0.7 0.1 to 2.8 0.95
OR estimated with ‘Median Unbiased Estimate’ displayed with an asterisk (*). ∞ = infinity
Statistical significance indicated in bold
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strengthen the evidence for implementation of this new
strategy as we showed that ICs were more commonly
diagnosed in HIV-positive persons than in matched con-
trols, in a period up to five years prior to HIV diagnosis.
HIV testing after detection of other STIs has already been
recommended for years. However, our results showed that
an HIV test is not always performed according to the
medical files. Our data showed no indication that the IC-
guided testing strategy would have a different effect in
sex- or age-based subgroups or in high-prevalence areas.
Discussion of findings
A Spanish cross-sectional study showed that offering
HIV testing to patients diagnosed with an IC could becost-effective in primary care since the prevalence of
HIV in these patients was higher than 0.1% for most of
the suggested ICs [28]. Also, this Spanish study showed
that ICs were frequently diagnosed by the GP, however,
HIV testing occurred in only 18.6% of the patients with
ICs. A Dutch case-control pilot study showed that more
than half of all cases (58.5%) in a high-prevalence area
had one or more ICs in the five years prior to HIV diag-
nosis [21]. A UK general practice case-control study
found that 25.8% of HIV cases had presented with an
ICs one year prior to the HIV diagnosis date [20]. In our
study, 44.2% of cases had one or more ICs one year prior
to the HIV diagnosis date. Also, a high number of cases
were from highly urbanised areas, which are known to
have a higher percentage of migrants [29]. The large
Table 5 Association of HIV diagnosis and HIV indicator conditions by gender, age group or urbanisation level
Cases Controls ORd 95% CI P value
n/N (%)a n/N (%)
for interaction
Total 136/224 60.7 411/2,193 18.7
Sex
Male 122/198 61.6 348/1,933 18.0 8.8 6.3 to 12.3 0.14
Female 14/26 53.8 63/260 24.2 4.3 1.8 to 10.4
Age category (at index date)
18 to 39 years 49/80 61.3 140/788 17.8 10.8 6.0 to 19.3
40 to 49 years 60/97 61.9 168/946 17.8 8.1 5.1 to 12.9 0.29
> 50 years 27/47 57.4 103/459 22.4 5.4 2.8 to 10.3
Urbanisation levelb
High urban (>2,500 addresses per km2) 42/76 55.3 117/633 18.5 7.4 4.2 to 13.0 0.49
Low urban (<2,500 addresses per km2) 58/83 69.9 201/948 21.2 9.7 5.7 to 16.2
Missingc 36/65 55.4 103/612 16.8
an = number of cases or controls with HIV indicator conditions, N = total number of cases or controls, % = percentage with HIV indicator condition
bHigh urban: >2,500 addresses per km2; low urban: < 2,500 addresses/km2
cSubjects with missing urbanisation level were not included in the analysis
dadditional effect of gender/age/urbanisation level on the likelihood for an HIV-diagnosis after presence of HIV indicator conditions
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where HIV is endemic, and who are known to present
to care late, may well account for the higher percentage
of ICs [2, 21]. This provider-initiated strategy could be
helpful in finding newly diagnosed HIV patients as early
as possible.
In a qualitative study, Dutch GPs suggested that
implementing the IC-guided testing might be more
beneficial in a higher HIV-prevalence area than in areas
with a lower HIV-prevalence [30]. In our study, no sig-
nificant differences were seen in the strength of the asso-
ciation between HIV diagnosis and ICs when comparing
genders, age groups or urbanisation levels. Our study
suggests that IC-guided testing is not restricted to high-
prevalence areas or subgroups.
Dutch national GP guidelines recommend that persons
in high-risk groups should be tested for all five major
STIs, namely chlamydia, gonorrhoea, hepatitis B, syphilis
and HIV [17]. In our study, 36.6% of the cases had one
or more STI(s) up to five years prior to diagnosis com-
pared to 3.0% of the controls. The European guidelines
recommend HIV testing for all STIs with an undiag-
nosed HIV prevalence of > 0.1% [18]. This implies that
all patients in the general population with an unspecified
STI diagnosis should be tested for HIV. In the
Netherlands, persons who are diagnosed with an STI in
primary care should be evaluated in terms of patient’s
risk-assessment and symptoms to determine whether
they should be further tested for STIs [11, 17]. Chla-
mydia is highly prevalent among Dutch patients who are
in groups that are presumed to have a low risk of HIV.There is still debate about the need to test for HIV in
primary care if chlamydia is found in a person not classi-
fied as being in a high-risk group [9]. Also, in our study
the ORs for gonorrhoea and syphilis were higher than
for chlamydia.
Acute HIV infection is a syndrome that can present as
a mononucleosis-like illness, and therefore its detection
can lead to the detection of HIV as early as possible.
Mononucleosis-like illness includes such symptoms as
fever, malaise, skin rash and generalised lymphadenop-
athy [31, 32]. Mononucleosis-like illness was reported in
1.3% of HIV cases in the five years prior to diagnosis
compared to 0.3% of the controls. The low percentage
found in the case group could be explained by the fact
that a mononucleosis-like illness is not always docu-
mented in the EMRs. Also, GPs are not always aware of
this acute syndrome [31, 32]. To increase the detection
of acute HIV infection, GPs could be better informed
about mononucleosis-like illness and the possible rela-
tionship with acute HIV infection.Strengths and limitations
This study was carried out in a GP network covering a
representative sample of the Dutch population. Cases
and ICs were searched for in the EMRs with the help of
open source information extraction algorithms, which
are known to significantly improve case detection when
combined with codes [33].
The controls were matched with the cases to limit
confounding. The selection of 10 controls per case
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rare events of ICs [26].
Reporting bias was minimised because the EMRs were
based on observations that were routinely recorded be-
fore the HIV diagnosis was made. Therefore, there is no
reason for differences between cases and controls in the
accuracy of the information collected.
During data extraction we searched for ICs defined as
‘symptoms’ (e.g. fever) in the evaluation line of the con-
sultation form (considered to be the final conclusion of
the GP), to avoid the risk of overestimating this IC (e.g.
fever often mentioned as complaint). As a result, an
underestimation is likely and associations between
symptoms and HIV diagnosis may be even stronger.
Not all ICs are likely to have been recorded in the
EMRs [34]. STIs may have been diagnosed elsewhere. In
the Netherlands, STI care is provided by GPs and STI
clinics [7, 17]. Results from STI clinics are not always
sent to the GP, which could cause an underestimation of
the number of ICs [11]. For the same reason, the pro-
portion not tested for HIV after an STI diagnosis may
have been overestimated, since HIV tests may be per-
formed at STI clinics. For example, we found that for
32% of persons diagnosed with syphilis, no HIV test was
reported in the same or follow-up consultation(s).
If a person had multiple consultations for an IC, we
used only the most recent one before the index date that
was recorded by the GP. A limitation is that the infor-
mation of repeated episodes was disregarded; a patient
could have been diagnosed multiple times with the same
IC prior to diagnosis, for example, multiple chlamydia
diagnoses. We chose for this method because it was dif-
ficult to determine from the records whether a condition
was diagnosed twice or if the same condition reap-
peared. This may have led to a slight underestimation of
the associations between IC conditions and HIV diagno-
sis; however, we still found quite strong and significant
associations.
Potential confounders or effect modifiers, such as
ethnicity, sexual preference and socioeconomic status,
could not be included in the analyses, because the
standard information recorded in patients’ medical
files does not include these characteristics [21]. In
other European countries, too, sexual risk behaviour
and sexual orientation are not included in EMRs in
primary care [15, 16]. However, the strength of IC-
guided testing is that it does not depend on patient
characteristics: HIV tests are not offered specificly to
groups labelled as being at risk and thereby avoids
potentially complex conversations about sexual risk
behaviour and/or ethnicity [15, 16, 35]. Therefore, ICs
could help GPs to bypass some of the barriers pre-
sented by these conversations and thus help to nor-
malise the use of the HIV test. [30]Conclusion
Our study showed that there are opportunities for
IC-guided testing in primary care in the Netherlands.
Unlike risk-based testing, this provider-initiated strategy
is also applicable for all patients.
The majority of the ICs in the European guideline are
not often seen by GPs, although all ICs are listed as rele-
vant for HIV testing in primary care [18]. We recom-
mend to determine a specific list of ICs that are more
commonly seen in primary care and thus help GPs to
implement IC-guided testing.
The context of pre-test information and how the HIV
test is offered when an IC is diagnosed is important if
patients are to agree to be tested [36, 37]. GPs should be
educated about the context of pre-test information and
how to offer an HIV test during IC-guided testing, for
example, by using an opt-out approach (‘You will be
tested unless you decline’). Many GPs use educational
tools to keep up to date and these are often the first step
in an implementation or change process [38]. We rec-
ommend that IC-guided testing should be better inte-
grated in GPs’ future guidelines and that education
strategies be developed to facilitate its implementation
in daily practice.Additional file
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